{"DataElement":{"publicId":"7642194","version":"1","preferredName":"Melanoma Mitotic Activity Rate Category","preferredDefinition":"A category which describes the dividing (proliferating) activity of atypical, neoplastic melanocytes tissue cells.","longName":"7642298v1.0:7642190v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7642298","version":"1","preferredName":"Melanoma Mitotic Activity","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain._Having to do with the presence of dividing (proliferating) cells. Cancerous tissue generally has more mitotic activity than normal tissues.","longName":"3108463v1.0:7222888v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"3108463","version":"1","preferredName":"Melanoma","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004","longName":"C3224","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"888ED2DC-38AD-7A5E-E040-BB89AD4317F2","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7222888","version":"1","preferredName":"Mitotic Activity","preferredDefinition":"Having to do with the presence of dividing (proliferating) cells. Cancerous tissue generally has more mitotic activity than normal tissues.","longName":"C35959","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Activity","conceptCode":"C35959","definition":"Having to do with the presence of dividing (proliferating) cells. Cancerous tissue generally has more mitotic activity than normal tissues.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1D98C4A-55A9-543B-E053-F662850AE7A6","latestVersionIndicator":"Yes","beginDate":"2020-03-27","endDate":null,"createdBy":"TSESU","dateCreated":"2020-03-27","modifiedBy":"ONEDATA","dateModified":"2020-03-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E47C3A-9509-556C-E053-4EBD850AA6E5","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeDescription":"7/28/21 jk upd OC to match other CM DEC format.  4/26/21 jk created for Phase 3 CM Baseline CRF.","administrativeNotes":"9/8/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7642190","version":"1","preferredName":"Melanoma Mitotic Rate Category","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain._Having to do with the presence of dividing (proliferating) cells. Cancerous tissue generally has more mitotic activity than normal tissues._A measurement of degree, speed, or frequency relative to time._A grouping of items based on some commonality or by user defined characteristics.","longName":"7642190v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not evaluated","valueDescription":"Source Data Not Available","ValueMeaning":{"publicId":"4842575","version":"1","preferredName":"Source Data Not Available","longName":"4842575","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"173BF844-9709-E098-E050-BB89AD431F3E","latestVersionIndicator":"Yes","beginDate":"2015-05-29","endDate":null,"createdBy":"LEEW","dateCreated":"2015-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E5FE3B-F3E3-2E6F-E053-4EBD850A7AE5","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"},{"value":">=1/mm2","valueDescription":"Mitotic Rate Greater than or Equal to One per Square Millimeter","ValueMeaning":{"publicId":"7642192","version":"1","preferredName":"Mitotic Rate Greater than or Equal to One per Square Millimeter","longName":"7642192","preferredDefinition":"A result of a mitotic rate equal to or greater than one per square millimeter.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Rate Greater than or Equal to One per Square Millimeter","conceptCode":"C158700","definition":"A result of a mitotic rate equal to or greater than one per square millimeter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E30B6E-845F-132E-E053-4EBD850AD2DC","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E30B6E-8478-132E-E053-4EBD850AD2DC","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"},{"value":"<1/ mm2","valueDescription":"<1/ mm2","ValueMeaning":{"publicId":"7642193","version":"1","preferredName":"<1/mm2","longName":"7642193v1.00","preferredDefinition":"A finding of a mitotic rate less than one per square millimeter.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Rate Less than One per Square Millimeter","conceptCode":"C179202","definition":"A finding of a mitotic rate less than one per square millimeter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E30B6E-8482-132E-E053-4EBD850AD2DC","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E30B6E-849B-132E-E053-4EBD850AD2DC","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7642326","version":"1","preferredName":"Melanoma Mitotic Activity Category","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.:Having to do with the presence of dividing (proliferating) cells. Cancerous tissue generally has more mitotic activity than normal tissues.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C3224:C35959:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mitotic Activity","conceptCode":"C35959","definition":"Having to do with the presence of dividing (proliferating) cells. Cancerous tissue generally has more mitotic activity than normal tissues.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E491C3-0973-6CC1-E053-4EBD850A79A9","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E30B6E-8445-132E-E053-4EBD850AD2DC","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeDescription":null,"administrativeNotes":"9/8/23: added concept code (C179202) and changed Datatype from APLPHNUMERIC to CHARACTER. Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7634324","version":"1","longName":"CM Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Mitotic Rate","type":"Preferred Question Text","description":"Mitotic Rate","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E3161A-DF59-2D6E-E053-4EBD850AEA5A","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeDescription":"7/28/21 jk upd sys gen def.  7/28/21 jk upd DEC to match CM DEC format.  4/26/21 ls created for Phase 3 CM Baseline CRF.","administrativeNotes":"9/8/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"}}